Clinical trial
A Multicenter, Randomized, Controlled, Double-Blind Trial on the Efficacy and Safety of Amygdala Temporal Interference Stimulation for the Treatment of Depression.
NCT06477276 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Controlled, Double-Blind Trial on the Efficacy and Safety of Amygdala Temporal Interference Stimulation for the Treatment of Depression.
- Lead sponsor
- Ruijin Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 24, 2024
- Completion date
- May 1, 2025
- Enrollment
- 92 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.